Stockreport

Versartis Appoints Eric Dobmeier to Board of Directors

VERSARTIS  (VSAR) 
Last versartis earnings: 7/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.versartis.com/investor-relations
PDF MENLO PARK, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a n [Read more]